Association between hepatosteatosis and severity of COVID-19 pneumonia: a CT-based study


Creative Commons License

Güldoğan E. S., ÖZBAL S., Akturk Y., Sencan İ., HEKİMOĞLU B.

Interdisciplinary medical journal, cilt.16, sa.56, ss.148-154, 2025 (TRDizin)

Özet

Objective: Recent studies show that comorbidities are a risk factor for coronavirus disease 2019 (COVID-19) pneumonia. We aimed to evaluate whether hepatosteatosis (HS) plays a role in predicting the severity of the disease. Method: We included 505 patients whose real-time polymerase chain reaction tests were positive and who had a thoracic computed tomography (CT) scan. Age, gender, height-weight, and comorbidities of the patients were noted. Three radiologists re-evaluated thoracic CTs, and the severity score (between 20-40 was considered a severe disease) was determined. Liver and spleen densities were measured by standardizing, the liver-spleen density ratio was selected, and steatosis was defined as ≤0.8. We used X2 and student t-test, logistic regression, and odds ratio with a 95% confidence interval. Results: In 149 (29.5%) patients, liver/spleen density ratios favored adiposity. The mean tomography severity score of the patients was 16 (±10.5). When we look at the distribution of 192 (38%) patients with a CT severity score of ≥20; the number of patients over 65 years of age and the male gender were higher. We also found a higher rate of HS in this group compared to the group with a lower CT severity score. When the correlation between the patients’ liver/spleen density ratios and the severity of pneumonia was examined, we observed that the severity of the disease increased significantly as the liver/spleen density ratio decreased (p<0.001). Conclusion: HS and age were independently related with severe COVID-19 pneumonia. For patients who have viral pneumonia, the liver-spleen density ratio might be measured.